Clinical trial · Observational
Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study
NCT03124394CI-TRIAL-00033895unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of clinical outcome and economical aspects in the treatment of patients with peritoneal carcinomatosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Peritoneal Carcinomatosis | Peritoneal Carcinomatosis | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- CRS and intraoperative chemotherapy
- description
- Patients receiving cytoreductive surgery and intraoperative chemotherapy (HIPEC/PIPAC)
Primary outcomes (4)
- measure
- Postoperative surgical complications
- timeFrame
- 90 days
- description
- Reporting and grading of postoperative surgical complications (according to Dindo)
- measure
- Rehospitalisation
- timeFrame
- 90 days
- description
- Rehospitalisation: (yes/no), time frame, cause of rehospitalisation
- measure
- Disease-free survival
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Men and Women \>18 years * Tumour board decision for CRS and intraoperative chemotherapy Exclusion Criteria: * Missing Tumour board decision for CRS and intraoperative chemotherapy * Pregnancy * Age \<18 years
References
Publications (0)
Data not yet available
No reference posted for this study.